Exercise for Cardiovascular Disease Prevention and Treatment From Molecular to Clinical, Part 1

(Elle) #1

222


References



  1. Rydén L, Grant PJ, Anker SD et al (2013) ESC guidelines on diabetes, pre-diabetes, and
    cardiovascular diseases developed in collaboration with the EASD: the task force on diabetes,
    pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and
    developed in collaboration with the European Association for the Study of diabetes (EASD).
    Eur Heart J 34:3035–3087

  2. Huynh K, Bernardo BC, McMullen JR et al (2014) Diabetic cardiomyopathy: mechanisms
    and new treatment strategies targeting antioxidant signaling pathways. Pharmacol Ther
    142:375–415

  3. Rubler S, Dlugash J, Yuceoglu ZY et al (1972) New type of cardiomyopathy associated with
    diabetic glomerulosclerosis. Am J Cardiol 30:595–602

  4. Palmieri V, Bella JN, Arnett DK et al (2001) Effect of type 2 diabetes mellitus on left ven-
    tricular geometry and systolic function in hypertensive subjects: hypertension genetic epide-
    miology network (HyperGEN) study. Circulation 103:102–107

  5. Boudina S, Abel ED (2010) Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab
    Disord 11:31–39

  6. Bell DS (2003) Diabetic cardiomyopathy. Diabetes Care 26:2949–2951

  7. Movahed MR, Hashemzadeh M, Jamal MM (2005) Diabetes mellitus is a strong, independent
    risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol
    105:315–318

  8. Zanuso S, Jimenez A, Pugliese G et al (2010) Exercise for the management of type 2 diabe-
    tes: a review of the evidence. Acta Diabetol 47:15–22

  9. Lancaster GI, Febbraio MA (2014) The immunomodulating role of exercise in metabolic
    disease. Trends Immunol 35:262–269

  10. Golbidi S, Laher I (2011) Molecular mechanisms in exercise induced cardioprotection.
    Cardiol Res Pract 2011:972807

  11. Dunstan DW, Daly RM, Owen N et  al (2002) High-intensity resistance training improves
    glycemic control in older patients with type 2 diabetes. Diabetes Care 25:1729–1736

  12. Broderick TL, Poirier P, Gillis M (2005) Exercise training restores abnormal myocardial
    glucose utilization and cardiac function in diabetes. Diabetes Metab Res Rev 21:44–50

  13. Brassard P, Legault S, Garneau C et al (2007) Normalization of diastolic dysfunction in type
    2 diabetics after exercise training. Med Sci Sports Exerc 39:1896–1901

  14. Tjonna AE, Lee SJ, Rognmo O et  al (2008) Aerobic interval training versus continuous
    moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation
    118:346–354

  15. Hafstad AD, Boardman NT, Lund J et al (2011) High intensity interval training alters substrate
    utilization and reduces oxygen consumption in the heart. J Appl Physiol 111:1235–1241

  16. Rodrigues B, Jorge L, Mostarda CT et al (2012) Aerobic exercise training delays cardiac
    dysfunction and improves autonomic control of circulation in diabetic rats undergoing myo-
    cardial infarction. J Cardiac Fail 18:734–744

  17. Byrkjeland R, Njerve IU, Anderssen S et al (2015) Effects of exercise training on HbA1c and
    VO2peak in patients with type 2 diabetes and coronary artery disease: a randomised clinical
    trial. Diabetes Vasc Dis Res 12:325–333

  18. Tabet JY, Meurin P, Driss AB et al (2009) Benefits of exercise training in chronic heart fail-
    ure. Arch Cardiovasc Dis 102:721–730

  19. Ellison GM, Waring CD, Vicinanza C et  al (2012) Physiological cardiac remodelling in
    response to endurance exercise training: cellular and molecular mechanisms. Heart Br Card
    Soc 98:5–10

  20. Hafstad AD, Boardman N, Aasum E (2015) How exercise may amend metabolic disturbances
    in diabetic cardiomyopathy. Antioxid Redox Signal 22(17):1587–1605


A.M. Mahmoud
Free download pdf